We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
34 hedge funds and large institutions have $1.58M invested in Sorrento Therapeutics, Inc. in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 189 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,286% more call options, than puts
Call options by funds: $97K | Put options by funds: $7K
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
85% less funds holding
Funds holding: 223 → 34 (-189)
97% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 189
99% less capital invested
Capital invested by funds: $176M → $1.58M (-$175M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
34
Holders Change
-189
Holders Change %
-84.75%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
3
Reduced
7
Closed
189
Calls
$97K
Puts
$7K
Net Calls
+$90K
Net Calls Change
-$1.07M
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$44.9M |
| 2 |
BlackRock
New York
|
-$34.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.2M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.89M |
| 5 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$4.62M |
